microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma.
Neuroblastoma is a common childhood tumor and accounts for 15% of pediatric cancer deaths. To investigate the microRNA (miRNA) profile and role of Dicer and Drosha in neuroblastoma, we assessed the expression of 162 human miRNAs, Dicer and Drosha in 66 neuroblastoma tumors by using real-time PCR methods. We found global downregulation of miRNA expression in advanced neuroblastoma and identified 27 miRNAs that can clearly distinguish low- from high-risk patients. Furthermore, expression levels of Dicer or Drosha were low in high-risk neuroblastoma tumors, which accounted for global downregulation of miRNAs in advanced disease and correlated with poor outcome. Notably, for patients with non-MYCN-amplified tumors, low expression of Dicer can serve as a significant and independent predictor of poor outcome (hazard ratio, 9.6; P = 0.045; n = 52). Using plausible neural networks to select a combination of 15 biomarkers that consist of 12 miRNAs' signature, expression levels of Dicer and Drosha, and age at diagnosis, we were able to segregate all patients into four distinct patterns that were highly predictive of clinical outcome. In vitro studies also showed that knockdown of either Dicer or Drosha promoted the growth of neuroblastoma cell lines. Our results reveal that a combination of 15 biomarkers can delineate risk groups of neuroblastoma and serve as a powerful predictor of clinical outcome. Moreover, our findings of growth promotion by silencing Dicer/Drosha implied their potential use as therapeutic targets for neuroblastoma.
Lin
Ruey-Jen
RJ
Graduate Institute of Life Science, National Defense Medical Center, and Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Lin
You-Chin
YC
Chen
Jeremy
J
Kuo
Huan-Hsien
HH
Chen
Yuan-Yan
YY
Diccianni
Mitchell B
MB
London
Wendy B
WB
Chang
Chih-Hao
CH
Yu
Alice L
AL
D045744:Cell Line, Tumor; D003114:Colony-Forming Units Assay; D017931:DNA Primers; D015870:Gene Expression; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D020868:Gene Silencing; D006801:Humans; D035683:MicroRNAs / Q000235:genetics*; D009447:Neuroblastoma / Q000201:enzymology / Q000453:epidemiology / Q000235:genetics*; D010957:Plasmids; D016133:Polymerase Chain Reaction / Q000379:methods; D011237:Predictive Value of Tests; D011379:Prognosis; D012333:RNA, Messenger / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics; D043244:Ribonuclease III / Q000172:deficiency / Q000235:genetics*; D018570:Risk Assessment; D014162:Transfection
D017931:DNA Primers; D035683:MicroRNAs; D012333:RNA, Messenger; D012334:RNA, Neoplasm; C517918:DROSHA protein, human; D043244:Ribonuclease III
Cancer Res. 2007 Feb 1;67(3):976-83
17283129
Cancer Res. 2005 Aug 15;65(16):7065-70
16103053
Oncogene. 2007 Oct 25;26(49):7017-27
17486064
Cancer Sci. 2005 Feb;96(2):111-5
15723655
Oncogene. 2008 Mar 13;27(12):1788-93
17891175
Eur J Cancer. 1997 Oct;33(12):2113-6
9516864
N Engl J Med. 2005 Nov 24;353(21):2243-53
16306521
Med Pediatr Oncol. 2001 Jan;36(1):28-31
11464899
Cancer Res. 2006 Jun 15;66(12):6050-62
16778177
Proteomics Clin Appl. 2008 Jan;2(1):55-62
21136779
PLoS One. 2009 Nov 16;4(11):e7850
19924232
Nucleic Acids Res. 2005 Sep 28;33(17):5394-403
16192569
Genes Dev. 2006 Aug 15;20(16):2202-7
16882971
J Pathol. 2007 Aug;212(4):368-77
17471471
Genes Chromosomes Cancer. 2007 Oct;46(10):936-49
17647283
Science. 1984 Jun 8;224(4653):1121-4
6719137
Cancer Lett. 2005 Oct 18;228(1-2):267-70
15913885
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9136-41
16754881
Nat Genet. 2007 May;39(5):673-7
17401365
Science. 2009 Aug 21;325(5943):965
19556464
N Engl J Med. 2008 Dec 18;359(25):2641-50
19092150
PLoS One. 2008 May 21;3(5):e2236
18493594
Cancer Res. 2007 May 15;67(10):4553-5
17510380
Oncogene. 2005 Nov 24;24(53):7902-12
16103881
Br J Cancer. 2007 Jul 16;97(2):238-46
17579628
Nat Rev Mol Cell Biol. 2005 May;6(5):376-85
15852042
Cancer Lett. 2007 Jun 8;250(2):250-67
17126996
Cancer Res. 2005 May 1;65(9):3509-12
15867338
Clin Cancer Res. 2006 Dec 15;12(24):7322-8
17121874
Eur J Cancer. 2007 Jul;43(10):1529-44
17531469
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6567-72
12011421
Nat Rev Cancer. 2003 Mar;3(3):203-16
12612655
Cancer Res. 2007 Mar 1;67(5):2345-50
17332367
Lancet. 2007 Jun 23;369(9579):2106-20
17586306
Oncogene. 2007 Nov 29;26(54):7590-5
17563749
Am J Pathol. 2006 Nov;169(5):1812-20
17071602
Cancer Res. 2006 Mar 1;66(5):2826-33
16510605
J Clin Oncol. 2006 Nov 1;24(31):5070-8
17075126
Int J Cancer. 1999 Jan 5;80(1):145-54
9935245